Progression to insulin deficiency in Korean patients with Type 2 diabetes mellitus positive for anti-GAD antibody

Diabetic Medicine

Volumn 28, Issue 3, 2011, Pages 319-324

  Lee, S A ^a   Lee, W J ^a   Kim, E H ^a   Yu, J H ^a   Jung, C H ^a   Koh, E H ^a   Kim, M S ^a   Park, J Y ^a   Lee, K U ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Anti GAD antibody; C peptide; Insulin deficiency; Type2 diabetes mellitus

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INSULIN DEFICIENCY; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 79851502087     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03186.x     Document Type: Article

References (15)

1. Littorin B, Sundkvist G, Hagopian W, Landin-Olsson M, Lernmark A, Ostman J et al. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type2 or unclassifiable diabetes. Diabetes Care 1999; 22: 409-412.
2. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR et al. UKPDS25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997; 350: 1288-1293.
3. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A et al. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia 1997; 40: 95-99.
4. Lee WJ, Lee HW, Palmer JP, Park KS, Lee HK, Park JY et al. Islet cell autoimmunity and mitochondrial DNA mutation in Korean subjects with typical and atypical TypeI diabetes. Diabetologia 2001; 44: 2187-2191.
5. Ko KS, Lee KU, Kim NH, Choi DS, Ihm SH, Park SW et al. The frequency of ICA and anti-GAD antibody in Korean IDDM and NIDDM patients. Korean Diabetes J 1998; 22: 312-319.
6. Lee SA, Kim EY, Kim EH, Jeong JY, Jeong EH, Kim DW et al. Anti-GAD antibody in patients with adult-onset diabetes in Korea. Korean Diabetes J 2009; 33: 16-23.
7. Genovese S, Bazzigaluppi E, Goncalves D, Ciucci A, Cavallo MG, Purrello F et al. Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol 2006; 154: 441-447.
8. Rosario PW, Reis JS, Fagundes TA, Calsolari MR, Amim R, Silva SC et al. Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization. Arq Bras Endocrinol Metabol 2007; 51: 52-58.
9. Van Deutekom AW, Heine RJ, Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med 2008; 25: 117-125.
10. Pettersen E, Skorpen F, Kvaloy K, Midthjell K, Grill V. Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Trondelag Health Study. Diabetes 2010; 59: 302-310.
11. Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C et al. Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study5). Diabet Med 2010; 27: 701-704.
12. Takino H, Yamasaki H, Abiru N, Sera Y, Abe T, Kawasaki E et al. Antibodies to GAD in Japanese patients classified as Type2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment-report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes. Diabet Med 2002; 19: 730-734.
13. Kobayashi T, Maruyama T, Shimada A, Kasuga A, Kanatsuka A, Takei I et al. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type1) diabetes mellitus. Ann N Y Acad Sci 2002; 958: 117-130.
14. Agardh CD, Lynch KF, Palmer M, Link K, Lernmark A. GAD65 vaccination: 5years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes. Diabetologia 2009; 52: 1363-1368.
15. Wentworth JM, Fourlanos S, Harrison LC. Reappraising the stereotypes of diabetes in the modern diabetogenic environment. Nat Rev Endocrinol 2009; 5: 483-489.